Efficacy and Safety of CKD-828 to Stage 2 Hypertension
NCT01634295
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
103
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
CKD-828 2.5/40mg
DRUG:
CKD-828 5/40mg
DRUG:
CKD-828 5/80mg
DRUG:
S-amlodipine 2.5mg
DRUG:
S-amlodipine 5mg
Sponsor
Chong Kun Dang Pharmaceutical